DK3443957T3 - Forbindelser og sammensætninger til behandling af cancer - Google Patents
Forbindelser og sammensætninger til behandling af cancer Download PDFInfo
- Publication number
- DK3443957T3 DK3443957T3 DK18191792.3T DK18191792T DK3443957T3 DK 3443957 T3 DK3443957 T3 DK 3443957T3 DK 18191792 T DK18191792 T DK 18191792T DK 3443957 T3 DK3443957 T3 DK 3443957T3
- Authority
- DK
- Denmark
- Prior art keywords
- compositions
- compounds
- cancer treatment
- cancer
- treatment
- Prior art date
Links
- 206010028980 Neoplasm Diseases 0.000 title 1
- 201000011510 cancer Diseases 0.000 title 1
- 150000001875 compounds Chemical class 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C57/00—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
- C07C57/30—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing six-membered aromatic rings
- C07C57/32—Phenylacetic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/513—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim having oxo groups directly attached to the heterocyclic ring, e.g. cytosine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
- C07C217/78—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having amino groups and etherified hydroxy groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton
- C07C217/80—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having amino groups and etherified hydroxy groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton having amino groups and etherified hydroxy groups bound to carbon atoms of non-condensed six-membered aromatic rings
- C07C217/82—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having amino groups and etherified hydroxy groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton having amino groups and etherified hydroxy groups bound to carbon atoms of non-condensed six-membered aromatic rings of the same non-condensed six-membered aromatic ring
- C07C217/84—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having amino groups and etherified hydroxy groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton having amino groups and etherified hydroxy groups bound to carbon atoms of non-condensed six-membered aromatic rings of the same non-condensed six-membered aromatic ring the oxygen atom of at least one of the etherified hydroxy groups being further bound to an acyclic carbon atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C229/06—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton
- C07C229/18—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton the nitrogen atom of the amino group being further bound to carbon atoms of six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/40—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino groups bound to carbon atoms of at least one six-membered aromatic ring and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C229/42—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino groups bound to carbon atoms of at least one six-membered aromatic ring and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton with carboxyl groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by saturated carbon chains
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
- C07C323/50—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
- C07C323/51—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
- C07C323/52—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C57/00—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
- C07C57/30—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C57/00—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
- C07C57/46—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing six-membered aromatic rings and other rings, e.g. cyclohexylphenylacetic acid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C57/00—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
- C07C57/46—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing six-membered aromatic rings and other rings, e.g. cyclohexylphenylacetic acid
- C07C57/48—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing six-membered aromatic rings and other rings, e.g. cyclohexylphenylacetic acid having unsaturation outside the aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/40—Unsaturated compounds
- C07C59/42—Unsaturated compounds containing hydroxy or O-metal groups
- C07C59/52—Unsaturated compounds containing hydroxy or O-metal groups a hydroxy or O-metal group being bound to a carbon atom of a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/40—Unsaturated compounds
- C07C59/42—Unsaturated compounds containing hydroxy or O-metal groups
- C07C59/54—Unsaturated compounds containing hydroxy or O-metal groups containing six-membered aromatic rings and other rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/40—Unsaturated compounds
- C07C59/76—Unsaturated compounds containing keto groups
- C07C59/84—Unsaturated compounds containing keto groups containing six membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C62/00—Compounds having carboxyl groups bound to carbon atoms of rings other than six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C62/18—Saturated compounds containing keto groups
- C07C62/20—Saturated compounds containing keto groups with a saturated six-membered ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C63/00—Compounds having carboxyl groups bound to a carbon atoms of six-membered aromatic rings
- C07C63/04—Monocyclic monocarboxylic acids
- C07C63/06—Benzoic acid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C63/00—Compounds having carboxyl groups bound to a carbon atoms of six-membered aromatic rings
- C07C63/04—Monocyclic monocarboxylic acids
- C07C63/06—Benzoic acid
- C07C63/08—Salts thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Emergency Medicine (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US40706910P | 2010-10-27 | 2010-10-27 | |
EP11856486.3A EP2632452B1 (en) | 2010-10-27 | 2011-10-26 | Compounds and compositions for the treatment of cancer |
Publications (1)
Publication Number | Publication Date |
---|---|
DK3443957T3 true DK3443957T3 (da) | 2020-12-21 |
Family
ID=46515034
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK18191792.3T DK3443957T3 (da) | 2010-10-27 | 2011-10-26 | Forbindelser og sammensætninger til behandling af cancer |
DK11856486.3T DK2632452T3 (da) | 2010-10-27 | 2011-10-26 | Forbindelser og sammensætninger til cancerbehandling |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK11856486.3T DK2632452T3 (da) | 2010-10-27 | 2011-10-26 | Forbindelser og sammensætninger til cancerbehandling |
Country Status (25)
Country | Link |
---|---|
US (2) | US9114118B2 (da) |
EP (2) | EP3443957B1 (da) |
JP (2) | JP6007186B2 (da) |
KR (2) | KR101821646B1 (da) |
CN (2) | CN103347509B (da) |
AU (2) | AU2011356583C1 (da) |
BR (1) | BR112013010507A2 (da) |
CA (1) | CA2816093C (da) |
CL (1) | CL2013001152A1 (da) |
DK (2) | DK3443957T3 (da) |
EA (2) | EA035494B1 (da) |
ES (2) | ES2837599T3 (da) |
HK (1) | HK1189836A1 (da) |
IL (2) | IL225599A (da) |
MX (2) | MX365807B (da) |
MY (2) | MY162420A (da) |
NZ (1) | NZ610851A (da) |
PH (1) | PH12016502324B1 (da) |
PL (2) | PL3443957T3 (da) |
PT (2) | PT2632452T (da) |
SG (2) | SG189538A1 (da) |
TR (1) | TR201819987T4 (da) |
TW (2) | TWI578983B (da) |
WO (1) | WO2012097427A1 (da) |
ZA (1) | ZA201303035B (da) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NZ610851A (en) * | 2010-10-27 | 2015-05-29 | Prometic Biosciences Inc | Compounds and compositions for the treatment of cancer |
TWI742541B (zh) | 2013-03-15 | 2021-10-11 | 英商邊緣生物科技有限公司 | 用於治療肺纖維化、肝纖維化、皮膚纖維化及心臟纖維化之經取代之芳族化合物 |
RU2560702C1 (ru) * | 2014-06-05 | 2015-08-20 | Общество с ограниченной ответственностью "Научно-производственный центр "Амфион" (ООО "НПЦ "Амфион") | Фармацевтическая композиция для применения в онкологии |
CA2963354A1 (en) | 2014-10-10 | 2016-04-14 | Prometic Biosciences Inc. | Substituted aromatic compounds and pharmaceutical compositions for the prevention and treatment of osteoporosis |
PL3204000T3 (pl) * | 2014-10-10 | 2020-07-27 | Liminal Biosciences Limited | Pochodne karboksylanów fenyloketonów i kompozycje farmaceutyczne do zapobiegania i leczenia osteoporozy |
MX2017006281A (es) * | 2014-11-12 | 2017-08-14 | Prometic Pharma Smt Ltd | Compuestos aromaticos substituidos y composiciones farmaceuticas para autorreparacion y regeneracion de tejido. |
CN106267213A (zh) * | 2015-05-27 | 2017-01-04 | 聊城市奥润生物医药科技有限公司 | 环二核苷酸cGAMP在治疗肿瘤联合用药中的应用 |
SG11201913251VA (en) | 2017-07-25 | 2020-01-30 | Taris Biomedical Llc | Methods of treating tumor metastasis |
JP2021502347A (ja) | 2017-11-08 | 2021-01-28 | タリス バイオメディカル エルエルシー | ゲムシタビンを使用した膀胱癌の治療及び維持療法の方法 |
AU2019393347A1 (en) * | 2018-12-05 | 2021-07-22 | Liminal Biosciences Limited | Use of sodium 2-(3-pentylphenyl)acetate in the treatment of alstrom syndrome |
US11246945B2 (en) | 2019-06-07 | 2022-02-15 | National Defense Medical Center | Cisplatin-loaded microbubbles, pharmaceutical composition for treatment of cancer, method for preparing pharmaceutical compositions and method for treating cancer |
JP2024512510A (ja) * | 2020-10-06 | 2024-03-19 | ファーマセウティーク・インジェニュー・インコーポレイテッド | 置換芳香族化合物及びその医薬組成物 |
CN114436822B (zh) * | 2022-01-12 | 2024-04-16 | 厦门稀土材料研究所 | 一枝蒿酮酸和生物碱复盐及其制备方法和用途 |
WO2024192529A1 (en) * | 2023-03-22 | 2024-09-26 | Uti Limited Partnership | Hydroxyphenyl propanoate compounds for tumour immunotherapy, compositions and uses thereof |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0268907A3 (en) * | 1986-11-19 | 1990-03-21 | Carl Richard Thornfeldt | Treatment of disease conditions relating to hyperactive organelles |
US5605930A (en) * | 1991-10-21 | 1997-02-25 | The United States Of America As Represented By The Department Of Health And Human Services | Compositions and methods for treating and preventing pathologies including cancer |
ITMI20012434A1 (it) * | 2001-11-20 | 2003-05-20 | Dompe Spa | Acidi 2-aril-propionici e composizioni farmaceutiche che li contengono |
CN1169768C (zh) * | 2002-04-26 | 2004-10-06 | 中国科学院上海有机化学研究所 | (4-炔基)-芳香酮酸类化合物、合成方法及应用 |
CN100558738C (zh) * | 2002-12-27 | 2009-11-11 | 泰博特克公司 | 酶的荧光底物及其制备方法 |
WO2005010202A2 (en) * | 2003-07-16 | 2005-02-03 | Ligand Pharmacueticals Incorporated | PHENYL ACETIC ACID DERIVATIVES AS HEPATOCYTE NUCLEAR FACTOR 4α (HNF-4α) MODULATOR COMPOUNDS |
WO2005009104A2 (en) * | 2003-07-16 | 2005-02-03 | Ligand Pharmacueticals Incorporated | Benzoic and phenyl acetic acid derivatives as hnf-4 modulators |
US8198328B2 (en) * | 2004-01-21 | 2012-06-12 | New York University | Treatment of cancer using benzoic acid derivatives |
ATE530176T1 (de) | 2006-09-01 | 2011-11-15 | Piramal Life Sciences Ltd | Verwendung von kaffeesäure und ihren derivaten gegen krebs |
JP5544169B2 (ja) * | 2007-02-08 | 2014-07-09 | エミスフェアー・テクノロジーズ・インク | フェニルアルキルカルボン酸誘導体送達剤 |
RU2519215C2 (ru) * | 2007-11-02 | 2014-06-10 | Прометик Байосайенсиз Инк. | Жирные кислоты и глицериды со средней длиной цепи в качестве нефропротективных средств |
WO2009055932A1 (en) * | 2007-11-02 | 2009-05-07 | Prometic Biosciences Inc. | Substituted phenylpropionic acids as stimulators of hematopoiesis and erythropoiesis |
CN101903028B (zh) | 2007-12-19 | 2013-06-05 | 普罗米蒂克生物科学公司 | 与吉西他滨组合用于治疗胰腺癌的中等链长脂肪酸、盐类及三酸甘油酯 |
TWI485134B (zh) * | 2009-05-04 | 2015-05-21 | 波麥堤克生化科學公司 | 取代的芳族化合物及其藥學用途 |
CA2761061A1 (en) * | 2009-05-04 | 2010-11-11 | Prometic Biosciences Inc. | Salts of 3-pentylphenylacetic acid and pharmaceutical uses thereof |
NZ610851A (en) * | 2010-10-27 | 2015-05-29 | Prometic Biosciences Inc | Compounds and compositions for the treatment of cancer |
-
2011
- 2011-10-26 NZ NZ610851A patent/NZ610851A/en not_active IP Right Cessation
- 2011-10-26 MY MYPI2013001522A patent/MY162420A/en unknown
- 2011-10-26 JP JP2013535215A patent/JP6007186B2/ja not_active Expired - Fee Related
- 2011-10-26 MY MYPI2017000606A patent/MY184343A/en unknown
- 2011-10-26 ES ES18191792T patent/ES2837599T3/es active Active
- 2011-10-26 BR BR112013010507A patent/BR112013010507A2/pt not_active Application Discontinuation
- 2011-10-26 KR KR1020137013238A patent/KR101821646B1/ko active IP Right Grant
- 2011-10-26 MX MX2013004832A patent/MX365807B/es active IP Right Grant
- 2011-10-26 WO PCT/CA2011/001179 patent/WO2012097427A1/en active Application Filing
- 2011-10-26 DK DK18191792.3T patent/DK3443957T3/da active
- 2011-10-26 CA CA2816093A patent/CA2816093C/en active Active
- 2011-10-26 PT PT11856486T patent/PT2632452T/pt unknown
- 2011-10-26 AU AU2011356583A patent/AU2011356583C1/en not_active Ceased
- 2011-10-26 ES ES11856486T patent/ES2703257T3/es active Active
- 2011-10-26 TW TW100138943A patent/TWI578983B/zh not_active IP Right Cessation
- 2011-10-26 US US13/882,355 patent/US9114118B2/en not_active Expired - Fee Related
- 2011-10-26 KR KR1020187001526A patent/KR101943280B1/ko active IP Right Grant
- 2011-10-26 DK DK11856486.3T patent/DK2632452T3/da active
- 2011-10-26 EA EA201791585A patent/EA035494B1/ru not_active IP Right Cessation
- 2011-10-26 CN CN201180052340.3A patent/CN103347509B/zh not_active Expired - Fee Related
- 2011-10-26 TW TW106101424A patent/TWI620563B/zh not_active IP Right Cessation
- 2011-10-26 PL PL18191792T patent/PL3443957T3/pl unknown
- 2011-10-26 CN CN201610353298.3A patent/CN105997967B/zh not_active Expired - Fee Related
- 2011-10-26 PT PT181917923T patent/PT3443957T/pt unknown
- 2011-10-26 TR TR2018/19987T patent/TR201819987T4/tr unknown
- 2011-10-26 EP EP18191792.3A patent/EP3443957B1/en active Active
- 2011-10-26 SG SG2013032354A patent/SG189538A1/en unknown
- 2011-10-26 EP EP11856486.3A patent/EP2632452B1/en active Active
- 2011-10-26 EA EA201370103A patent/EA030038B1/ru not_active IP Right Cessation
- 2011-10-26 PL PL11856486T patent/PL2632452T3/pl unknown
- 2011-10-26 SG SG10201807622WA patent/SG10201807622WA/en unknown
-
2013
- 2013-04-07 IL IL225599A patent/IL225599A/en active IP Right Grant
- 2013-04-25 ZA ZA2013/03035A patent/ZA201303035B/en unknown
- 2013-04-26 MX MX2019007010A patent/MX2019007010A/es unknown
- 2013-04-26 CL CL2013001152A patent/CL2013001152A1/es unknown
-
2014
- 2014-04-01 HK HK14103126.5A patent/HK1189836A1/zh not_active IP Right Cessation
-
2015
- 2015-07-13 US US14/797,957 patent/US9439882B2/en not_active Expired - Fee Related
-
2016
- 2016-03-10 AU AU2016201556A patent/AU2016201556B2/en not_active Ceased
- 2016-08-04 JP JP2016153378A patent/JP6371344B2/ja not_active Expired - Fee Related
- 2016-11-22 PH PH12016502324A patent/PH12016502324B1/en unknown
-
2017
- 2017-03-10 IL IL251083A patent/IL251083B/en active IP Right Grant
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK3443957T3 (da) | Forbindelser og sammensætninger til behandling af cancer | |
DK2585437T3 (da) | Thioacetatforbindelser, sammensætninger og fremgangsmåder til anvendelse heraf | |
DK3329775T3 (da) | Fremgangsmåder til syntese af diarylthiohydantoin- og diarylhydantoinforbindelser | |
DK2558105T3 (da) | Bardoxolonmethyl til behandling af fedme | |
DK2532366T3 (da) | Farmaceutisk sammensætning til behandling og/eller forebyggelse af cancer | |
DK2818482T3 (da) | Farmaceutisk sammensætning til behandling af cancer | |
DK2824114T3 (da) | Farmaceutisk sammensætning til behandling af cancer | |
DK3517534T3 (da) | Forbindelser, der er anvendelige til behandling af cancer | |
DK3289876T3 (da) | Forbindelser til behandling af cancer | |
BRPI1011587A2 (pt) | compostos e composições terapèuticas | |
DK2699553T3 (da) | Substituerede diaminocarboxamid- og diaminocarbonitrilpyrimidiner, sammensætninger deraf og fremgangsmåder til behandling dermed | |
DK3520805T3 (da) | Sammensætninger til behandling af myelofibrose | |
DK2763665T3 (da) | Antimikrobielle sammensætninger og fremgangsmåder til anvendelse deraf | |
DK3434687T3 (da) | Hidtil ukendte oxyntomodulinderivater og farmaceutisk præparat til behandling af fedme omfattende samme | |
DK3444342T3 (da) | Fremgangsmåder og sammensætninger til behandlingen af lysosomale aflejringssygdomme | |
DK2941258T3 (da) | Sammensætninger og fremgangsmåder til behandling af cancer ved anvendelse af bakterier | |
DK2776567T3 (da) | Sammensætninger og fremgangsmåder til behandling af cytomegalovirus. | |
DK2688557T3 (da) | Fremgangsmåder og sammensætninger til behandling af forstyrelse af opmærksomhed | |
DK2398902T3 (da) | Fremgangsmåder og sammensætninger til diagnosticering og behandling af cancer | |
DK2785349T3 (da) | Kombinationsbehandling af cancer | |
DK2635282T3 (da) | Sammensætninger til behandling af myelofibrose | |
BR112012032683A2 (pt) | composição | |
DK3246042T3 (da) | Lægemiddelresistent immunterapi til behandling af cancer | |
BRPI1007972A2 (pt) | composições de combinação e métodos para o tratamento de câncer | |
DK2598500T3 (da) | Sammensætninger og fremgangsmåder til hæmning af jak-reaktionsvejen |